Home
>
National Drug Code (NDC)
>
Isradipine
Isradipine - 16252-539-01 - (Isradipine)
Drug Information of Isradipine
| Product NDC: | 16252-539 |
| Proprietary Name: | Isradipine |
| Non Proprietary Name: | Isradipine |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Isradipine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Isradipine
| Product NDC: | 16252-539 |
| Labeler Name: | Cobalt Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077317 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040105 |
Package Information of Isradipine
| Package NDC: | 16252-539-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (16252-539-01) |
NDC Information of Isradipine
| NDC Code | 16252-539-01 |
| Proprietary Name | Isradipine |
| Package Description | 100 CAPSULE in 1 BOTTLE (16252-539-01) |
| Product NDC | 16252-539 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Isradipine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20040105 |
| Marketing Category Name | ANDA |
| Labeler Name | Cobalt Laboratories |
| Substance Name | ISRADIPINE |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
